CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,796 | +95.7% | 1,035 | +137.9% | 0.00% | – |
| Q2 2023 | $24,421 | -15.0% | 435 | -31.5% | 0.00% | – |
| Q1 2023 | $28,721 | +11.3% | 635 | 0.0% | 0.00% | – |
| Q4 2022 | $25,813 | -37.0% | 635 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $41,000 | +5.1% | 635 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | +160.0% | 635 | +159.2% | 0.00% | – |
| Q1 2022 | $15,000 | -21.1% | 245 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | +280.0% | 245 | +444.4% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 45 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | – | 45 | +800.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 5 | -99.2% | 0.00% | – |
| Q4 2018 | $17,000 | -37.0% | 600 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | -22.9% | 600 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $35,000 | +29.6% | 600 | 0.0% | 0.00% | – |
| Q1 2018 | $27,000 | +92.9% | 600 | 0.0% | 0.00% | – |
| Q4 2017 | $14,000 | +27.3% | 600 | 0.0% | 0.00% | – |
| Q3 2017 | $11,000 | +10.0% | 600 | 0.0% | 0.00% | – |
| Q2 2017 | $10,000 | -23.1% | 600 | 0.0% | 0.00% | – |
| Q1 2017 | $13,000 | +8.3% | 600 | 0.0% | 0.00% | – |
| Q4 2016 | $12,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |